6.83
price up icon1.49%   0.10
pre-market  プレマーケット:  6.32   -0.51   -7.47%
loading

Fulcrum Therapeutics Inc (FULC) 最新ニュース

pulisher
Aug 03, 2025

Fulcrum Therapeutics Inc. Stock Analysis and ForecastAchieve breakthrough gains with smart trades - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Fulcrum Therapeutics Inc. stock higher in 2025Build wealth with long-term growth strategies - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Fulcrum Therapeutics Inc. in the next 12 monthsBuild a portfolio that stands the test of time - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Fulcrum Therapeutics Inc. stock attracting strong analyst attentionMassive stock growth - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Is Fulcrum Therapeutics Inc. a good long term investmentUnlock powerful trading strategies for gains - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Fulcrum Therapeutics Inc. stockBuild a winning investment strategy today - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Fulcrum Therapeutics Inc. stockAchieve impressive returns with smart timing - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

What is Fulcrum Therapeutics Inc. company’s growth strategyUnlock powerful market insights for success - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

Fulcrum Therapeutics shares slide 17% after sickle cell trial results - MSN

Aug 03, 2025
pulisher
Aug 03, 2025

Technical signs of recovery in Fulcrum Therapeutics Inc.Price Spike Prediction for Active Traders - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Entry Optimization Guide with Volume Analysis - Newser

Aug 03, 2025
pulisher
Aug 02, 2025

When is Fulcrum Therapeutics Inc. stock expected to show significant growthFree Market Dynamics Reports - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

How strong is Fulcrum Therapeutics Inc. company’s balance sheetMaximize returns with timely market signals - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

How does Fulcrum Therapeutics Inc. generate profit in a changing economyHigh-profit capital plays - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

What institutional investors are buying Fulcrum Therapeutics Inc. stockInvest smarter with cutting-edge analytics - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

Is Fulcrum Therapeutics Inc. stock overvalued or undervaluedAccess exclusive market insights for free - jammulinksnews.com

Aug 02, 2025
pulisher
Aug 02, 2025

FY2025 EPS Estimates for FULC Raised by Cantor Fitzgerald - Defense World

Aug 02, 2025
pulisher
Aug 02, 2025

Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningTrend Confirmation Scanner with Entry Focus - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Will Fulcrum Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsOversold Opportunity Scanner with RSI Data - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Q3 Earnings Forecast for FULC Issued By Leerink Partnrs - Defense World

Aug 02, 2025
pulisher
Aug 02, 2025

Is Fulcrum Therapeutics Inc. stock ready for a breakoutReal-Time AI Entry Forecast Generator - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Free Portfolio Diversification Stock Ideas - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Are Bears Losing Grip on Fulcrum Therapeutics Inc.Reliable Investment Entry Signals Confirmed by Charts - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

How to interpret RSI for Fulcrum Therapeutics Inc. stockTen-Year Sector Performance and Summary Analysis - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

How many analysts rate Fulcrum Therapeutics Inc. as a “Buy”Wealth Building Picks That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Receives $6.29 Consensus Target Price from Brokerages - Defense World

Jul 31, 2025
pulisher
Jul 31, 2025

Key External Factors That Drive Fulcrum Therapeutics Inc. Stock Price MovementsAI Trading Suggestions With Accuracy Focus Released - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

Fulcrum Therapeutics stock price target raised to $5 at RBC Capital - Investing.com Canada

Jul 30, 2025
pulisher
Jul 30, 2025

Fulcrum Therapeutics (NASDAQ:FULC) Rating Increased to Buy at HC Wainwright - Defense World

Jul 30, 2025
pulisher
Jul 30, 2025

Is Fulcrum Therapeutics Inc. building a consolidation baseTrend Following Ideas with Volume Confirmation - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 02:00:45 - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Fulcrum Therapeutics 2024 Q2 Earnings Strong Turnaround with Net Income Swing of 333% - AInvest

Jul 30, 2025
pulisher
Jul 29, 2025

H.C. Wainwright upgrades Fulcrum Therapeutics stock rating on promising SCD data - Investing.com Canada

Jul 29, 2025
pulisher
Jul 29, 2025

Buy Rating for Fulcrum Therapeutics: Promising Potential of Pociredir in Sickle Cell Disease Treatment - TipRanks

Jul 29, 2025
pulisher
Jul 29, 2025

HC Wainwright Raises Fulcrum Therapeutics' PT to $12 from $4 - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Inc. Stock Fails to Break Resistance Traders ReactDaily Smart Money Movement Monitor Activated - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics, Inc. SEC 10-Q Report - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Plunges 29.58% on PIONEER Trial Results - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Inc. (FULC) Tops Q2 EPS by 1c - StreetInsider

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics stock falls after sickle cell disease trial results - Investing.com Australia

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease - The Manila Times

Jul 29, 2025
pulisher
Jul 29, 2025

Fulcrum Therapeutics Reports Positive Results from Phase 1b PIONEER Trial of Pociredir for Sickle Cell Disease - Quiver Quantitative

Jul 29, 2025
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):